Page last updated: 2024-08-21

alpha-aminopyridine and Lung Diseases

alpha-aminopyridine has been researched along with Lung Diseases in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Page, C; Stolfa, I1
Abraham, J; Budd, GT; Dalpiaz, N; Jazieh, KA1
Berra, G; Gianella, P; Glatz, N; Janssens, JP1
Chan, HC; Chen, J; Chen, Y; Dong, ZW; Peng, YZ; Ruan, YC; Tsang, LL; Zhou, T1
Gillissen, A; Häussermann, A1
Bleyer, M; Braun, A; Fieguth, HG; Förster, C; Fuchs, E; Hohlfeld, JM; Kaup, FJ; Knauf, S; Lauenstein, HD; Neuhaus, V; Pfennig, O; Schlumbohm, C; Seehase, S; Sewald, K; Switalla, S1
Dai, YR; Xia, XD; Xu, ZJ1
Doggrell, SA1

Reviews

3 review(s) available for alpha-aminopyridine and Lung Diseases

ArticleYear
[New therapeutic options in pulmonary diseases in 2016 : focus on asthma, COPD and idiopathic pulmonary fibrosis (IPF)].
    Revue medicale suisse, 2017, Jan-11, Volume: 13, Issue:544-545

    Topics: Aminopyridines; Asthma; Benzamides; Cyclopropanes; Humans; Idiopathic Pulmonary Fibrosis; Lung Diseases; Pulmonary Disease, Chronic Obstructive; Pulmonary Medicine; Therapies, Investigational

2017
[Diseases of the lung and air passages 2010].
    Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:25-26

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aminopyridines; Asthma; Benzamides; Cyclopropanes; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Indans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Phosphodiesterase 4 Inhibitors; Pneumonia, Bacterial; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinolones

2010
[Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2004, Volume: 27, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Asthma; Benzamides; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Lung Diseases; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridines

2004

Other Studies

5 other study(ies) available for alpha-aminopyridine and Lung Diseases

ArticleYear
Phosphodiesterase inhibitors and lung diseases.
    Advances in pharmacology (San Diego, Calif.), 2023, Volume: 98

    Topics: Aminopyridines; Humans; Lung Diseases; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive

2023
Can CDK4/6 inhibitors cause fatal lung injury?
    Expert review of anticancer therapy, 2019, Volume: 19, Issue:11

    Topics: Aminopyridines; Antineoplastic Agents; Benzimidazoles; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Humans; Lung Diseases; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines

2019
CFTR-regulated MAPK/NF-κB signaling in pulmonary inflammation in thermal inhalation injury.
    Scientific reports, 2015, Oct-30, Volume: 5

    Topics: Aminopyridines; Animals; Benzodioxoles; Cell Line; Curcumin; Cyclooxygenase 2; Cystic Fibrosis Transmembrane Conductance Regulator; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Hot Temperature; Inflammation; Inhalation; Interleukin-8; JNK Mitogen-Activated Protein Kinases; Lung Diseases; Male; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; NF-kappa B; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Up-Regulation

2015
LPS-induced lung inflammation in marmoset monkeys - an acute model for anti-inflammatory drug testing.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Aged; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Bronchoalveolar Lavage Fluid; Callithrix; Cyclopropanes; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Immunosuppressive Agents; Inflammation; Inflammation Mediators; Lipopolysaccharides; Lung; Lung Diseases; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Tumor Necrosis Factor-alpha

2012
Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Aminopyridines; Anti-Inflammatory Agents; Asthma; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Humans; Lung Diseases; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pulmonary Ventilation; Randomized Controlled Trials as Topic

2006